169 related articles for article (PubMed ID: 27662590)
1. Knockdown of Serine-Arginine Protein Kinase 1 Inhibits the Growth and Migration in Renal Cell Carcinoma Cells.
Han X; Yang J; Jia Z; Wei P; Zhang H; Lv W; Sun J; Huo Q
Oncol Res; 2017 Mar; 25(3):389-395. PubMed ID: 27662590
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
3. The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas.
Ren G; Sheng L; Liu H; Sun Y; An Y; Li Y
Med Oncol; 2015 Jul; 32(7):209. PubMed ID: 26099172
[TBL] [Abstract][Full Text] [Related]
4. Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.
Zhao Z; Liu H; Hou J; Li T; Du X; Zhao X; Xu W; Xu W; Chang J
Oncol Res; 2017 May; 25(5):773-779. PubMed ID: 27983909
[TBL] [Abstract][Full Text] [Related]
5. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
6. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
7. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
[TBL] [Abstract][Full Text] [Related]
8. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
9. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-specific peptidase 46 (USP46) suppresses renal cell carcinoma tumorigenesis through AKT pathway inactivation.
Gui D; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Biochem Biophys Res Commun; 2019 Nov; 519(4):689-696. PubMed ID: 31542232
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of TACC3 Inhibits the Proliferation and Invasion of Human Renal Cell Carcinoma Cells.
Guo F; Liu Y
Oncol Res; 2018 Mar; 26(2):183-189. PubMed ID: 28109075
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of ETS2 inhibits the invasion and metastasis of renal cell carcinoma cells by inducing EMT via the PI3K/Akt signaling pathway.
Zhang GW; Tian X; Li Y; Wang ZQ; Li XD; Zhu CY
Biomed Pharmacother; 2018 Aug; 104():119-126. PubMed ID: 29772431
[TBL] [Abstract][Full Text] [Related]
14. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway.
Lian JH; Wang WH; Wang JQ; Zhang YH; Li Y
Asian Pac J Cancer Prev; 2013; 14(9):5017-21. PubMed ID: 24175769
[TBL] [Abstract][Full Text] [Related]
16. SRPK1 contributes to malignancy of hepatocellular carcinoma through a possible mechanism involving PI3K/Akt.
Zhou B; Li Y; Deng Q; Wang H; Wang Y; Cai B; Han ZG
Mol Cell Biochem; 2013 Jul; 379(1-2):191-9. PubMed ID: 23644876
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
19. The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.
Chang Y; Wu Q; Tian T; Li L; Guo X; Feng Z; Zhou J; Zhang L; Zhou S; Feng G; Han F; Yang J; Huang F
Tumour Biol; 2015 Aug; 36(8):6083-93. PubMed ID: 25833691
[TBL] [Abstract][Full Text] [Related]
20. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
